Vontobel Holding’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $447K | Sell |
11,642
-470
| -4% | -$18K | ﹤0.01% | 821 |
|
|
2025
Q1 | $469K | Buy |
12,112
+1,437
| +13% | +$55.7K | ﹤0.01% | 802 |
|
|
2024
Q4 | $361K | Buy |
10,675
+280
| +3% | +$9.47K | ﹤0.01% | 874 |
|
|
2024
Q3 | $425K | Sell |
10,395
-953
| -8% | -$39K | ﹤0.01% | 831 |
|
|
2024
Q2 | $437K | Sell |
11,348
-499
| -4% | -$19.2K | ﹤0.01% | 809 |
|
|
2024
Q1 | $508K | Sell |
11,847
-1,228
| -9% | -$52.6K | ﹤0.01% | 767 |
|
|
2023
Q4 | $485K | Sell |
13,075
-878
| -6% | -$32.5K | ﹤0.01% | 804 |
|
|
2023
Q3 | $506K | Sell |
13,953
-2,554
| -15% | -$92.6K | ﹤0.01% | 766 |
|
|
2023
Q2 | $588K | Buy |
+16,507
| New | +$588K | 0.01% | 750 |
|
|
2022
Q3 | – | Sell |
-18,350
| Closed | -$998K | – | 1060 |
|
|
2022
Q2 | $998K | Sell |
18,350
-3,168
| -15% | -$172K | 0.01% | 540 |
|
|
2022
Q1 | $1.17M | Sell |
21,518
-9,686
| -31% | -$528K | 0.01% | 571 |
|
|
2021
Q4 | $1.72M | Buy |
31,204
+98
| +0.3% | +$5.4K | 0.01% | 481 |
|
|
2021
Q3 | $1.49M | Buy |
31,106
+4,163
| +15% | +$199K | 0.01% | 515 |
|
|
2021
Q2 | $1.34M | Sell |
26,943
-778,172
| -97% | -$38.7M | 0.01% | 524 |
|
|
2021
Q1 | $35.9M | Sell |
805,115
-6,697
| -0.8% | -$299K | 0.27% | 50 |
|
|
2020
Q4 | $37.3M | Buy |
+811,812
| New | +$37.3M | 0.24% | 50 |
|